Address: Insure Insights 61 Bridge Street, Kington.HR5 3DJ United Kingdom

Global Consumer Healthcare Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Global Consumer Healthcare Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Global Consumer Healthcare Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Global Consumer Healthcare Market Outlook 2028: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 13 Apr 2021
  • Report ID: HLT 00180
  • Pages:169
  • Base Year: 2019
  • Format: PDF
  • Historical Data:2016-2019

Global Consumer Healthcare Market is anticipated to rise at a value CAGR of 9.2% over 2019-2028. According to a study published by Insure Insights on the Global Consumer Healthcare Market. Consumer Healthcare is a term used to empower individuals or consumers to self-manage ones, health and encourage self-medications like (Over the Counter) OTC drugs. It was traditionally accomplished through over-the-counter medications and the consumer-health care movement that was led by the pharmaceutical companies. They include products for nutrition, skincare, also includes drugs like analgesic, antacids, etc. The upsurge in the commercialization of the OTC drugs in various forms through media and entertainments have proved to be lucrative to the market growth

Top Driver: The increases in awareness among consumers about various healthcare products

The rise in the awareness among the consumers about a variety of products, rise in the incidences of minor ailments like cold cough, the need for vitamins, minerals are driving the market growth. The rise in the disposable incomes among the public, growth in the elderly population, growth in the overall population have escalated the growth. The government initiatives for the development of OTC generic have further expanded the market revenue

OTC Pharmaceuticals has dominated growth in the Global Consumer Healthcare Market

Based on the Product OTC Pharmaceuticals segment, has obtained the highest growth due to an increase in the rise in the incidence in the illness like cold, cough, Fever, etc. The prevalence of Muscle pain in every age, especially in adults and the elderly have further enhanced the segmental growth. The rise in the allergies induce by bacteria and fungus and advertisement related to the use of these OTC pharmaceuticals has expanded the growth of the market. The demand for antacids, vitamins, protein, minerals, herbal remedies, other drugs have further improved the segmental growth

In terms of the Distribution Network, Pharmacy segment has obtained the most remarkable growth owing to the high availability of OTC products in pharmacies. The development of Modernized systems in pharmacies has boosted segmental growth. The advent of Online Pharmacies has further expanded the growth of the market

North America boosts the regional market due to the Technologically advanced products  

North America has held the highest market growth owing to the availability of technologically advanced products and the rise in disposable income among the public is the primary factor boosting the regional market; moreover, the minor health ailments in children and elderly have further boosted the market growth.  The Asia Pacific region  is expected to grow as the second largest market owing to the significant rise in the population growth, lifestyle diseases,  have enhanced the regional market growth

Product launches, Strategic Collaborations, Mergers, and Acquisition, are the major strategies of the competitors

The Players of the Global Consumer Healthcare Market is fragmented. Product launches, Product launches, Collaborations, Mergers, and Acquisition, are strategies used by the competitors   The key competitors of the Global Consumer Healthcare Market are, BASF, BioGaia, Bukwang Pharmaceutical, Abbott Laboratories, American Health, Arena Pharmaceuticals, Danone, Euradite Consumer Health and Life Care, Johnson Nutrition, and The Himalaya Drug Company.

The Himalaya Drug Company: The Himalaya Drug Company, is one of the key competitors of the Global Consumer Healthcare Market; for instance, In November 2019, Himalaya had announced the launch of Quista kidz, it is a nutritional supplement formulated for children aged from 3 to 10 years. It is used for active growth, building strong immunity, and also for supporting smart memory in children. The product is made up of 100% milk protein, minerals, and vitamins.

Danone:  Danone is a popular competitor in the Global Consumer Healthcare Market. In May 2020, Danone had announced the launch of plant-based Vega One protein products for China. This product is a drink used for fitness enthusiasts. Vega One Protein is a combination of protein sources. It includes pea, sunflower, alfalfa, and pumpkin seed proteins and is free of GMOs, as well as artificial colors and flavorings.

Scope of the Report

By Product

  • OTC Pharmaceuticals
  • Dietary Supplements

By Distribution Network

  • Pharmacy
  • Supermarkets
  • Departmental Stores
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • LAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1           Overview And Scope

1.1             Market Vision

1.1.1          Market Definition

1.1.2          Market Scope

1.2             Market Segmentation

Chapter 2           Our Research Practice

2.1             Our Research Methodology

2.2             Data Triangulation

2.3             Data Sources

2.4             Assumptions for the study

2.5             Approach Adopted

Chapter 3           Executive Summary

3.1             Market Snapshot

3.2             Regional Snapshot

3.3             Segment Summary

Chapter 4           Covid-19 Impact Analysis

4.1             Overview

4.2             Prevalence analysis

4.3             Key Factor Impact Analysis

Chapter 5           Global Consumer Healthcare Market Forces

5.1             What’s Driving the Market

5.2             Porter’s Five Forces Analysis

5.2.1          Power of Suppliers

5.2.2          Threats From New Entrants

5.2.3          Power of Buyer

5.2.4          Threat From Substitute Product

5.2.5          Degree of Competition

Chapter 6           Global Consumer Healthcare Market -Industry Snapshots

6.1             Overview

6.1.1          Global Consumer Healthcare Market Value, 2019 – 2026, (US$ Bn)

6.2             Market Overview

6.2.1          Drivers Analysis

6.2.2          Restraint/Challenges analysis

6.2.3          Opportunity Analysis

6.3             Supply Chain/Value Chain Analysis

6.4             Market SWOT Analysis

Chapter 7           Global Consumer Healthcare Market Analysis, by Product

7.1             Overview

7.2             Key Findings for Consumer Healthcare Market- By Product

7.2.1          Consumer Healthcare Market- OTC Pharmaceuticals

7.2.2          Consumer Healthcare Market- Dietary Supplements

Chapter 8           Global Consumer Healthcare Market Analysis, by Distribution Network

8.1             Overview

8.2             Key Findings for Consumer Healthcare Market- By Distribution Network

8.2.1          Consumer Healthcare Market- Pharmacy

8.2.2          Consumer Healthcare Market- Supermarkets

8.2.3          Consumer Healthcare Market- Departmental Stores

8.2.4          Consumer Healthcare Market- Others

Chapter 9           Consumer Healthcare Market Analysis by Region

9.1             Key Findings for Consumer Healthcare Market- By region

9.2             Overview

9.2.1          Global Consumer Healthcare Market Analysis, By Product, 2019 – 2026

9.2.2          Global Consumer Healthcare Market Analysis, By Distribution Network, 2019 – 2026

9.3             Consumer Healthcare Market – North America

9.3.1          Overview

9.3.2          U.S.

9.3.3          Canada

9.3.4          Mexico

9.3.5          North America Market, By Product

9.3.6          North America Market, By Distribution Network

9.4             Consumer Healthcare Market – Europe

9.4.1          Overview

9.4.2          Germany

9.4.3          United Kingdom

9.4.4          France

9.4.5          Italy

9.4.6          Rest Of Europe

9.4.7          Europe Market, By Product

9.4.8          Europe Market, By Distribution Network

9.5             Consumer Healthcare Market – Asia Pacific

9.5.1          Overview

9.5.2          China

9.5.3          Japan

9.5.4          India

9.5.5          Rest of APAC

9.5.6          Asia Pacific Market, By Product

9.5.7          Asia Pacific Market, By Distribution Network

9.6             Consumer Healthcare Market – LAMEA

9.6.1          Overview

9.6.2          Middle East & Africa (MEA)

9.6.3          Latin America

9.6.4          Rest Of World

9.6.5          Latin America, Middle East and Africa Market, By Product

9.6.6          Latin America, Middle East and Africa Market, By Distribution Network

Chapter 10       Market Competition Analysis

10.1           Market Share/Positioning Analysis

10.1.1       Market Positioning of Key Vendors, 2019

10.1.2       Key Strategies Adopted by the Leading Players

10.1.3       Recent Developments

Chapter 11       Company Profiles- Snapshot

11.1           BASF

11.1.1       Business Fundamentals

11.1.2       Financial Snapshots

11.1.3       Product Portfolio

11.1.4       Recent Developments

11.2           BioGaia

11.3           Bukwang Pharmaceutical

11.4           Abbott Laboratories

11.5           American Health

11.6           Arena Pharmaceuticals

11.7           Danone

11.8           Euradite Consumer Health and Life Care

11.9           Johnson Nutrition

11.10        The Himalaya Drug Company

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 12       Appendix

 

 

 

 

Request for Sample

Please fill out the form to receive sample pages of the report